Skip to main content
TipRanks
Go Ultimate75% OFF

Bio-Techne (TECH) Stock Statistics & Valuation Metrics

536 Followers

Total Valuation

Bio-Techne has a market cap or net worth of $11.41B. The enterprise value is $11.38B.

Market Cap
$11.41B
Enterprise Value
$11.38B

Share Statistics

Bio-Techne has 157,090,730 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
157,090,730
Owned by Insiders
0.33%
Owned by Institutions
94.12%

Financial Efficiency

Bio-Techne’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 7.81%.

Return on Equity (ROE)
0.09
Return on Assets (ROA)
0.07
Return on Invested Capital (ROIC)
7.81%
Return on Capital Employed (ROCE)
0.10
Revenue Per Employee
405.01K
Profits Per Employee
60.62K
Employee Count
3,000
Asset Turnover
0.47
Inventory Turnover
2.13

Valuation Ratios

The current PE Ratio of Bio-Techne is 66.08. Bio-Techne’s PEG ratio is 0.55.

PE Ratio
66.08
PS Ratio
9.30
PB Ratio
5.26
Price to FCF
37.05
Price to Operating Cash Flow
33.76
PEG Ratio
0.55

Income Statement

In the last 12 months, Bio-Techne had revenue of 1.22B and earned 181.86M in profits. Earnings per share was 1.17.

Revenue
1.22B
Gross Profit
799.07M
Operating Income
251.89M
Pretax Income
240.68M
Net Income
181.86M
EBITDA
343.44M
Earnings Per Share (EPS)
1.17

Cash Flow

In the last 12 months, operating cash flow was 337.60M and capital expenditures -29.40M, giving a free cash flow of 308.20M billion.

Operating Cash Flow
337.60M
Free Cash Flow
308.20M
Free Cash Flow per Share
1.97

Dividends & Yields

Bio-Techne pays an annual dividend of $0.08, resulting in a dividend yield of 0.55%

Dividend Per Share
$0.08
Dividend Yield
0.55%
Payout Ratio
16.49%
Free Cash Flow Yield
2.70%
Earnings Yield
1.51%

Stock Price Statistics

Beta
0.84
52-Week Price Change
23.92%
50-Day Moving Average
72.45
200-Day Moving Average
63.06
Relative Strength Index (RSI)
63.85
Average Volume (3m)
2.89M

Important Dates

Bio-Techne upcoming earnings date is Feb 02, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 03, 2026
Next Earnings Date
Feb 02, 2027
Ex-Dividend Date
May 18, 2026

Financial Position

Bio-Techne as a current ratio of 4.55, with Debt / Equity ratio of 13.71%

Current Ratio
4.55
Quick Ratio
3.35
Debt to Market Cap
0.02
Net Debt to EBITDA
0.07
Interest Coverage Ratio
46.60

Taxes

In the past 12 months, Bio-Techne has paid 58.82M in taxes.

Income Tax
58.82M
Effective Tax Rate
0.24

Enterprise Valuation

Bio-Techne EV to EBITDA ratio is 34.51, with an EV/FCF ratio of 36.81.

EV to Sales
9.24
EV to EBITDA
34.51
EV to Free Cash Flow
36.81
EV to Operating Cash Flow
33.60

Balance Sheet

Bio-Techne has $351.13M in cash and marketable securities with $285.56M in debt, giving a net cash position of $65.57M billion.

Cash & Marketable Securities
$351.13M
Total Debt
$285.56M
Net Cash
$65.57M
Net Cash Per Share
$0.42
Tangible Book Value Per Share
$5.78

Margins

Gross margin is 65.75%, with operating margin of 19.61%, and net profit margin of 14.00%.

Gross Margin
65.75%
Operating Margin
19.61%
Pretax Margin
18.51%
Net Profit Margin
14.00%
EBITDA Margin
26.77%
EBIT Margin
18.89%

Analyst Forecast

The average price target for Bio-Techne is $73.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell

Price Target
$73.00
Price Target Upside
0.51% Upside
Analyst Consensus
Moderate Sell
Analyst Count
3
Revenue Growth Forecast
0.94%
EPS Growth Forecast
122.38%

Scores

Smart Score
5
AI Score
74